People Aren’t Buying Highs; They Are Buying Dips

[video_player type=”youtube” youtube_remove_logo=”Y” width=”640″ height=”360″ align=”center” margin_top=”0″ margin_bottom=”20″]aHR0cHM6Ly95b3V0dS5iZS9vU25tVllMRzZ3RQ==[/video_player]

U.S. equities slide for a fourth consecutive session on mixed earnings although stocks parred losses to end the day nearly unchanged. One of the top stories today was President Trump meeting with various heads of top Pharma companies (LLY, MRK, etc.), and the group has seen a bounce (biotech as well) following commentary he will soon announce a new FDA leader whose mission, in part, will be to speed the drug approval process (helping names like PFE and LLY which missed earnings earlier turn higher and lift biotech by 2%). All eyes on AAPL after the close posting record revenue and an all time record in $246 billion cash. Key events this week will include the FOMC meeting (starts today with results tomorrow – as expectations are for rates to remain on hold while waiting for more clarity on fiscal policy) and the monthly jobs data released on Friday.
And to learn more about pairs trading opportunities join Don Kaufman for a free online seminar called, ““The Right Trading Strategy for 2017 and Beyond” sign up here: https://theotrade.com/snap/

More from TheoTrade

Why The Fed Raises Rates Wednesday

Most Of What’s Green Today Is Garbage

Why I Scrapped This 36-Cent Spread

Stories Are For Children Not For Traders

Why Algorithms Squeeze Every Early Short

Why the Crash Calls Are Weeks Too Late

Most Recent

Why The Fed Raises Rates Wednesday
Most Of What’s Green Today Is Garbage
Why I Scrapped This 36-Cent Spread
Stories Are For Children Not For Traders
Why Algorithms Squeeze Every Early Short

Get educational market insights sent right to your inbox.

As Seen In